ILA 1088.0
(0.28%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -2.35 Million ILS | -461.34% |
2022 | - ILS | -103.2% |
2021 | 13.09 Million ILS | 131.93% |
2020 | - ILS | -1459.64% |
2019 | -2.62 Million ILS | -128.37% |
2018 | 7.39 Million ILS | 236.32% |
2017 | -6.79 Million ILS | -135.21% |
2016 | 15.54 Million ILS | 15.65% |
2015 | 15.66 Million ILS | -81.2% |
2014 | 89.31 Million ILS | 24.69% |
2013 | 71.22 Million ILS | 106.56% |
2012 | 35.92 Million ILS | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q1 | 433.5 Thousand ILS | 510.9% |
2023 Q2 | 433.5 Thousand ILA | 0.0% |
2023 FY | - ILS | -461.34% |
2023 Q3 | -12 Thousand ILS | -102.77% |
2023 Q4 | -12 Thousand ILA | 0.0% |
2022 Q2 | 534 Thousand ILA | 0.0% |
2022 Q4 | -105.5 Thousand ILA | 0.0% |
2022 FY | - ILS | -103.2% |
2022 Q1 | - ILS | 100.0% |
2022 Q3 | -105.5 Thousand ILS | -119.76% |
2021 Q1 | -169 Thousand ILS | 96.98% |
2021 FY | - ILS | 131.93% |
2021 Q3 | -377 Thousand ILS | -123.08% |
2021 Q4 | -377 Thousand ILS | 0.0% |
2021 Q2 | -169 Thousand ILS | 0.0% |
2020 Q3 | -9.03 Million ILS | -43.33% |
2020 Q2 | -6.3 Million ILS | 71.94% |
2020 FY | - ILS | -1459.64% |
2020 Q1 | -22.45 Million ILS | -73.47% |
2020 Q4 | -5.6 Million ILS | 37.94% |
2019 Q4 | -12.94 Million ILS | -466.58% |
2019 FY | - ILS | -128.37% |
2019 Q1 | 3.3 Million ILS | 128.3% |
2019 Q2 | 3.48 Million ILS | 5.58% |
2019 Q3 | 3.53 Million ILS | 1.35% |
2018 Q4 | -11.65 Million ILS | -238.25% |
2018 Q2 | 6.97 Million ILS | 91.39% |
2018 Q1 | 3.64 Million ILS | 135.55% |
2018 FY | - ILS | 236.32% |
2018 Q3 | 8.43 Million ILS | 20.85% |
2017 FY | - ILS | -135.21% |
2017 Q4 | -10.25 Million ILS | -299.67% |
2017 Q3 | 5.13 Million ILS | 317.72% |
2017 Q2 | -2.35 Million ILS | -446.4% |
2017 Q1 | 681 Thousand ILS | 112.63% |
2016 Q3 | 6.61 Million ILS | -5.34% |
2016 Q1 | 7.32 Million ILS | 2642.32% |
2016 Q4 | -5.39 Million ILS | -181.44% |
2016 Q2 | 6.99 Million ILS | -4.52% |
2016 FY | - ILS | 15.65% |
2015 Q4 | 267 Thousand ILS | -94.4% |
2015 Q3 | 4.76 Million ILS | 0.85% |
2015 Q2 | 4.72 Million ILS | -19.82% |
2015 Q1 | 5.89 Million ILS | -91.4% |
2015 FY | - ILS | -81.2% |
2014 Q1 | -4.09 Million ILS | -11.92% |
2014 Q3 | 11.19 Million ILS | 126.42% |
2014 Q4 | 68.56 Million ILS | 512.61% |
2014 FY | - ILS | 24.69% |
2014 Q2 | 4.94 Million ILS | 220.71% |
2013 FY | - ILS | 106.56% |
2013 Q4 | -3.65 Million ILS | 26.75% |
2013 Q1 | -5.18 Million ILS | 0.0% |
2013 Q2 | -4.78 Million ILS | 7.86% |
2013 Q3 | -4.99 Million ILS | -4.5% |
2012 FY | - ILS | 0.0% |
Name | EBITDA | EBITDA Difference |
---|